Retatrutide's mechanism of action centres on its simultaneous activation of GLP-1, GIP, and glucagon receptors
Current research does not show that BPC-157 directly raises circulating testosterone or growth hormone levels in healthy adults
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
Many clients at Soza Clinic report feeling more consistent energy during workouts and less prolonged soreness afterward when maintaining regular B12 therapy alongside their training programs
Reviewed by the PeptideMind Team Updated July 19, 2026 BPC-157 vs TB-500: The Wolverine peptide stack comparison BPC-157 acts locally at the site of injury